Autoimmune Rheumatic Diseases: An Update on the Role of Atherogenic Electronegative LDL and Potential Therapeutic Strategies.

Chen, Der-Yuan; Sawamura, Tatsuya; Dixon, Richard A F; Sánchez-Quesada, José Luis; Chen, Chu-Huang

Chen, Der-Yuan; Sawamura, Tatsuya; Dixon, Richard A F; Sánchez-Quesada, José Luis; Chen, Chu-Huang.

Afiliação

Chen DY; Translational Medicine Center, China Medical University Hospital, Taichung 404, Taiwan.
Sawamura T; Rheumatology and Immunology Center, China Medical University Hospital, Taichung 404, Taiwan.
Dixon RAF; College of Medicine, China Medical University, Taichung 404, Taiwan.
Sánchez-Quesada JL; Department of Molecular Pathophysiology, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Chen CH; Department of Life Innovation, Institute for Biomedical Sciences, Shinshu University, Matsumoto 390-8621, Japan.

J Clin Med ; 10(9)2021 May 06.

Article em En | MEDLINE | ID: mdl-34066436

Palavras-chave

L5; atherosclerotic cardiovascular disease (ASCVD); autoimmune rheumatic diseases (AIRDs); electronegative LDL; interleukin 1ß (IL-1ß); lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article